GMM Pfaudler Q2 FY26 EBITDA rose 27% to ₹122 crore, driven by non-glasslined growth and strong orders. SEMCO Brazil ...

Earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 31% from last year to ₹121.4 crore, while ...

Novo Nordisk currently offers a direct-to-consumer option for those willing to pay cash for Ozempic and Wegovy, at $499 a month. Lilly also offers cash-pay options for its weight-loss drug Zepbound ...

The world's oil supply is expected to enter an extreme glut in 2026. Just how big that overhang will be is complicated.